Last reviewed · How we verify
Non-antithrombotic group — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Non-antithrombotic group (Non-antithrombotic group) — OCEAN-SHD Study Group. This is a descriptive category rather than a specific drug, referring to medications that do not prevent blood clots through anticoagulation or antiplatelet mechanisms.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Non-antithrombotic group TARGET | Non-antithrombotic group | OCEAN-SHD Study Group | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Non-antithrombotic group CI watch — RSS
- Non-antithrombotic group CI watch — Atom
- Non-antithrombotic group CI watch — JSON
- Non-antithrombotic group alone — RSS
Cite this brief
Drug Landscape (2026). Non-antithrombotic group — Competitive Intelligence Brief. https://druglandscape.com/ci/non-antithrombotic-group. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing